SLC5A2 and diabetes mellitus: When Lut used in combination with hypoglycemic drugs such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists, may become an ideal clinical medication regimen for patients with diabetes complicated with cardiovascular complications, reducing the occurrence of cardiovascular events.